PortfoliosLab logoPortfoliosLab logo
CLB vs. BA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLB vs. BA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Core Laboratories NV (CLB) and The Boeing Company (BA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLB achieves a -26.48% return, which is significantly lower than BA's 1.71% return. Over the past 10 years, CLB has underperformed BA with an annualized return of -19.93%, while BA has yielded a comparatively higher 6.70% annualized return.


CLB

1D
0.68%
1M
-17.23%
YTD
-26.48%
6M
-28.96%
1Y
-4.88%
3Y*
-19.72%
5Y*
-22.36%
10Y*
-19.93%

BA

1D
-0.85%
1M
0.83%
YTD
1.71%
6M
1.84%
1Y
11.11%
3Y*
2.44%
5Y*
-1.94%
10Y*
6.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLB vs. BA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CLB
Core Laboratories NV
-26.48%-7.12%-1.76%-12.72%-8.97%-15.73%-29.05%-34.35%-44.49%-6.83%
BA
The Boeing Company
1.71%22.67%-32.10%36.84%-5.38%-5.95%-33.90%3.34%11.50%94.72%

Correlation

The correlation between CLB and BA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Sep 21, 1995

0.24

The correlation between CLB and BA shifts across timeframes, from 0.06 (1 year) to 0.28 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLB:

$542.28M

BA:

$180.68B

EPS

CLB:

$0.67

BA:

$2.90

PE Ratio

CLB:

17.67

BA:

76.11

PEG Ratio

CLB:

0.98

BA:

11.92

PS Ratio

CLB:

1.05

BA:

1.87

PB Ratio

CLB:

1.97

BA:

30.21

Total Revenue (TTM)

CLB:

$524.73M

BA:

$92.18B

Gross Profit (TTM)

CLB:

$73.89M

BA:

$4.43B

EBITDA (TTM)

CLB:

$70.89M

BA:

$7.13B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLB vs. BA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLB
CLB Risk / Return Rank: 3838
Overall Rank
CLB Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
CLB Sortino Ratio Rank: 3939
Sortino Ratio Rank
CLB Omega Ratio Rank: 3838
Omega Ratio Rank
CLB Calmar Ratio Rank: 3939
Calmar Ratio Rank
CLB Martin Ratio Rank: 3737
Martin Ratio Rank

BA
BA Risk / Return Rank: 5151
Overall Rank
BA Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
BA Sortino Ratio Rank: 4949
Sortino Ratio Rank
BA Omega Ratio Rank: 4747
Omega Ratio Rank
BA Calmar Ratio Rank: 5353
Calmar Ratio Rank
BA Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLB vs. BA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Core Laboratories NV (CLB) and The Boeing Company (BA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLBBADifference
Sharpe ratioReturn per unit of total volatility

-0.43

Sortino ratioReturn per unit of downside risk

-0.44

Omega ratioGain probability vs. loss probability

1.04

1.09

-0.05

Calmar ratioReturn relative to maximum drawdown

-0.12

0.45

-0.56

Martin ratioReturn relative to average drawdown

-0.30

1.01

-1.31

CLB vs. BA - Sharpe Ratio Comparison

The current CLB Sharpe Ratio is -0.08, which is lower than the BA Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of CLB and BA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLB vs. BA - Drawdown Comparison

The maximum CLB drawdown since its inception was -95.78%, which is greater than BA's maximum drawdown of -89.45%. Use the drawdown chart below to compare losses from any high point for CLB and BA.


Loading charts...

Drawdown Indicators


CLBBADifference

Max Drawdown

Largest peak-to-trough decline

-95.78%

-89.45%

-6.33%

Max Drawdown (1Y)

Largest decline over 1 year

-41.81%

-24.96%

-16.85%

Max Drawdown (3Y)

Largest decline over 3 years

-64.29%

-48.31%

-15.98%

Max Drawdown (5Y)

Largest decline over 5 years

-76.91%

-53.76%

-23.15%

Max Drawdown (10Y)

Largest decline over 10 years

-93.50%

-77.92%

-15.58%

Current Drawdown

Current decline from peak

-93.70%

-48.68%

-45.02%

Average Drawdown

Average peak-to-trough decline

-41.43%

-31.02%

-10.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.12%

11.05%

+5.07%

Volatility

CLB vs. BA - Volatility Comparison

Core Laboratories NV (CLB) has a higher volatility of 13.86% compared to The Boeing Company (BA) at 11.15%. This indicates that CLB's price experiences larger fluctuations and is considered to be riskier than BA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLBBADifference

Volatility (1M)

Calculated over the trailing 1-month period

13.86%

11.15%

+2.71%

Volatility (6M)

Calculated over the trailing 6-month period

34.54%

23.78%

+10.76%

Volatility (1Y)

Calculated over the trailing 1-year period

58.56%

32.31%

+26.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.80%

36.62%

+17.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.03%

41.66%

+13.37%

Dividends

CLB vs. BA - Dividend Comparison

CLB's dividend yield for the trailing twelve months is around 0.34%, while BA has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BA
The Boeing Company
0.00%0.00%0.00%0.00%0.00%0.00%0.96%2.52%2.12%1.93%2.80%2.52%
CLB
Core Laboratories NV
0.34%0.25%0.23%0.23%0.20%0.18%1.06%5.84%3.69%2.01%1.83%2.02%

Financials

CLB vs. BA - Financials Comparison

This section allows you to compare key financial metrics between Core Laboratories NV and The Boeing Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
121.80M
22.22B
(CLB) Total Revenue
(BA) Total Revenue
Values in USD except per share items

CLB vs. BA - Profitability Comparison

The chart below illustrates the profitability comparison between Core Laboratories NV and The Boeing Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%-10.0%0.0%10.0%20.0%202220232024202520260
11.5%
Portfolio components
CLB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Core Laboratories NV reported a gross profit of 0.00 and revenue of 121.80M. Therefore, the gross margin over that period was 0.0%.

BA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported a gross profit of 2.55B and revenue of 22.22B. Therefore, the gross margin over that period was 11.5%.

CLB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Core Laboratories NV reported an operating income of 1.89M and revenue of 121.80M, resulting in an operating margin of 1.6%.

BA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported an operating income of 448.00M and revenue of 22.22B, resulting in an operating margin of 2.0%.

CLB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Core Laboratories NV reported a net income of -789.00K and revenue of 121.80M, resulting in a net margin of -0.7%.

BA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Boeing Company reported a net income of -4.00M and revenue of 22.22B, resulting in a net margin of -0.0%.


Frequently Asked Questions


CLB and BA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLB has higher volatility (13.86%) compared to BA (11.15%). In terms of maximum drawdown, CLB dropped -95.78% vs BA's -89.45%.

BA currently has the higher Sharpe Ratio (0.35 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLB and BA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer